ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.32
-0.65%
US Tech 100
18,577.00
0.23%
S&P 500
5,366.61
0.25%
US Dollar vs CAD
1.37525
0.61%
Bitcoin
70,771.24
0.01%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Biosante Pharmaceuticals (BPA)

  7. Biosante Pharmaceuticals (BPA) News

BPA

Biosante Pharma (BPA)

Biosante Pharmaceuticals
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:BPA
DateTimeSourceHeadlineSymbolCompany
10/31/20074:21PMEdgar (US Regulatory)Biosante Pharmaceuticals Inc - Amended Securities Registration (section 12(b)) (8-A12B/A)AMEX:BPABiosante Pharmaceuticals
10/24/200710:23AMEdgar (US Regulatory)Biosante Pharmaceuticals Inc - Current report filing (8-K)AMEX:BPABiosante Pharmaceuticals
10/24/200710:23AMEdgar (US Regulatory)Biosante Pharmaceuticals Inc - Current report filingAMEX:BPABiosante Pharmaceuticals
10/24/200710:23AMEdgar (US Regulatory)Biosante Pharmaceuticals Inc - Current report filingAMEX:BPABiosante Pharmaceuticals
09/24/200712:57PMPR Newswire (US)WallSt.net Announces Upcoming Interview with CEO of BioSante PharmaceuticalsAMEX:BPABiosante Pharmaceuticals
08/14/20073:15PMBusiness WireBioSante Pharmaceuticals Reports Second Quarter 2007 Financial ResultsAMEX:BPABiosante Pharmaceuticals
08/08/20077:00AMBusiness WireBioSante Pharmaceuticals to Present at Upcoming ConferencesAMEX:BPABiosante Pharmaceuticals
07/25/20077:00AMBusiness WireBioSante Pharmaceuticals Announces Positive Results for its CaP Technology for Use in Aesthetic MedicineAMEX:BPABiosante Pharmaceuticals
07/11/20077:00AMBusiness WireBioSante Pharmaceuticals Announces New Findings for Potential Bird Flu VaccineAMEX:BPABiosante Pharmaceuticals
07/10/20076:00AMPR Newswire (US)WallSt.net (www.wallst.net ) Updates the Investment Community Through All-New Interviews with BPA, PPCO and NVAXAMEX:BPABiosante Pharmaceuticals
06/28/20076:00AMBusiness WireBioSante Pharmaceuticals, Inc. Joins Russell Microcap IndexAMEX:BPABiosante Pharmaceuticals
06/19/20077:00AMBusiness WireBioSante Pharmaceuticals Announces Oral Contraceptive Phase II Study InitiationAMEX:BPABiosante Pharmaceuticals
06/14/20077:00AMBusiness WireBioSante Pharmaceuticals Completes $18.3 Million Private Placement of Common StockAMEX:BPABiosante Pharmaceuticals
06/13/20077:45AMPR Newswire (US)Bradley Pharmaceuticals Announces Launch of Elestrin(TM)AMEX:BPABiosante Pharmaceuticals
05/30/20078:12AMBusiness WireBioSante Pharmaceuticals to Present at Upcoming ConferencesAMEX:BPABiosante Pharmaceuticals
05/25/20078:26AMBusiness WireBioSante Pharmaceuticals Announces $16.5 Million Private Placement of Common StockAMEX:BPABiosante Pharmaceuticals
05/16/20077:00AMBusiness WireBioSante Pharmaceuticals to Present at Upcoming ConferencesAMEX:BPABiosante Pharmaceuticals
05/07/20077:00AMBusiness WireBioSante Pharmaceuticals Signs Oral Contraceptive License with Pantarhei BioscienceAMEX:BPABiosante Pharmaceuticals
05/04/20077:45AMPR Newswire (US)Bradley Pharmaceuticals to Preview New Products at ACOG MeetingAMEX:BPABiosante Pharmaceuticals
05/02/20076:45AMBusiness WireBioSante Pharmaceuticals to Present at Upcoming ConferencesAMEX:BPABiosante Pharmaceuticals
05/01/20074:00PMBusiness WireBioSante Pharmaceuticals Reports First Quarter 2007 Financial ResultsAMEX:BPABiosante Pharmaceuticals
04/11/20077:45AMPR Newswire (US)Bradley Pharmaceuticals' Elestrin(TM) Receives New Patent to 2022AMEX:BPABiosante Pharmaceuticals
04/10/20077:00AMBusiness WireBioSante Pharmaceuticals Announces Issuance of New Patent Covering Elestrin(TM) and LibiGel(R)AMEX:BPABiosante Pharmaceuticals
04/02/20071:09PMPR Newswire (US)Dawson James Securities Reiterates Strong Buy Recommendation on Antares Pharma (Amex: AIS) with $4.00 Price TargetAMEX:BPABiosante Pharmaceuticals
03/26/20076:30AMBusiness WireBioSante Pharmaceuticals Receives Milestone Payment from Bradley PharmaceuticalsAMEX:BPABiosante Pharmaceuticals
03/08/20073:34PMBusiness WireBioSante Pharmaceuticals Reports Net Profit of $2.8 million for 2006 And Investor Conference CallAMEX:BPABiosante Pharmaceuticals
03/08/20077:00AMBusiness WireBioSante Pharmaceuticals to Present at Upcoming ConferencesAMEX:BPABiosante Pharmaceuticals
01/30/20077:00AMBusiness WireBioSante Pharmaceuticals Announces Positive Bird Flu Results Using Proprietary Vaccine Adjuvant in Pre-Clinical StudyAMEX:BPABiosante Pharmaceuticals
01/16/20078:00AMBusiness WireStephen M. Simes, President and CEO of BioSante Pharmaceuticals, Inc., Talks to The Wall Street TranscriptAMEX:BPABiosante Pharmaceuticals
12/19/20066:45AMPR Newswire (US)Bradley Pharmaceuticals Announces FDA Approval of Elestrin(TM) (estradiol gel 0.06%)AMEX:BPABiosante Pharmaceuticals
 Showing the most relevant articles for your search:AMEX:BPA

Your Recent History

LSE
88ZD
Sigma Fin.nts09
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved